![]() |
|
|
Vol. 299, Issue 2, 638-644, November 2001
Department of Pathology and Center for the Study of Liver Diseases, The University of Hong Kong, Hong Kong, China (A.A.N.); Research Unit of Alcohol Diseases, Helsinki University Central Hospital, Helsinki, Finland (K.J.); Department of Anatomy, The University of Hong Kong, Hong Kong, China (G.L.T.); Department of Pathology, Harvard Medical School, Boston, Massachusetts (A.R.); and Department of Medicine, Weill Medical College of Cornell University and Anne Fisher Nutrition Center at Strang Cancer Prevention Center, New York, New York (A.J.D.)
| |
Abstract |
|---|
|
|
|---|
We investigated the potential of dietary saturated fatty acids to
reverse alcoholic liver injury despite continued administration of
alcohol. Five groups (six rats/group) of male Wistar rats were studied.
Rats in groups 1 and 2 were fed a fish oil-ethanol diet for 8 and 6 weeks, respectively. Rats in groups 3 and 4 were fed fish oil and
ethanol for 6 weeks before being switched to isocaloric diets
containing ethanol with palm oil (group 3) or medium-chain triglycerides (MCTs, group 4) for 2 weeks. Rats in group 5 were fed
fish oil and dextrose for 8 weeks. Liver samples were analyzed for
histopathology, lipid peroxidation, nuclear factor-
B (NF-
B) activation, and mRNAs for cyclooxygenase-2 (Cox-2) and tumor necrosis factor-
(TNF-
). Endotoxin in plasma was determined. The most severe inflammation and fibrosis were detected in groups 1 and 2, as
were the highest levels of endotoxin, lipid peroxidation, activation of
NF-
B, and mRNAs for Cox-2 and TNF-
. After the rats were switched
to palm oil or MCT, there was marked histological improvement with
decreased levels of endotoxin and lipid peroxidation, absence of
NF-
B activation, and reduced expression of TNF-
and Cox-2. A diet
enriched in saturated fatty acids effectively reverses alcohol-induced
necrosis, inflammation, and fibrosis despite continued alcohol
consumption. The therapeutic effects of saturated fatty acids may be
explained, at least in part, by reduced endotoxemia and lipid
peroxidation, which in turn result in decreased activation of NF-
B
and reduced levels of TNF-
and Cox-2.
| |
Introduction |
|---|
|
|
|---|
Long-term treatment of alcoholic
liver disease continues to incorporate vitamins, nutrients, and trace
elements (Fulton and McCullough, 1998
; McCullough et al., 1998
). In
fact, the role of specific pharmacological agents remains unproven.
Clearly, the development of more effective nutritional or
pharmacological therapy will depend on further elucidating the
mechanisms that contribute to liver injury.
Several lines of investigation indicate that dietary fat can modulate
the severity of alcoholic liver injury (Mezey, 1998
). In experimental
animals, for example, diets enriched with saturated fatty acids protect
against alcohol-induced liver injury, whereas diets containing
polyunsaturated fatty acids promote liver injury (Nanji and French,
1989
; Nanji et al., 1989
, 1994a
). Saturated fatty acids have also been
reported to reverse established alcoholic liver injury (Nanji et al.,
1995
, 1996
, 1997b
). Importantly, in previous studies, use of alcohol
was discontinued at the time that dietary treatment was initiated. This
model represented the alcoholic patient who stopped drinking at the
time of hospitalization (French, 1995
).
Discontinuation of alcohol remains pivotal in the treatment of
alcoholic liver disease. Although this goal can frequently be achieved
in the short-term, the majority of patients resume alcohol consumption,
often with sudden deterioration in liver disease (Pares et al., 1986
).
Hence, it is important to develop therapeutic strategies that simulate
the clinical condition in which alcohol use is continued despite the
presence of alcoholic liver disease.
Previously, we used the intragastric feeding rat model to study the
pathogenesis of alcoholic liver disease (Nanji et al., 1999
). In
addition to being useful for elucidating mechanisms of injury, this
model has been used to evaluate various strategies to prevent or
reverse alcoholic liver disease (Nanji et al., 1995
, 1997b
). The
results of previous studies suggest that elevated levels of endotoxin
and lipid peroxides in alcohol-fed animals activate nuclear factor-
B
(NF-
B), leading to enhanced expression of tumor necrosis factor-
(TNF-
), cyclooxygenase-2 (Cox-2), and proinflammatory cytokines
(Nanji et al., 1997a
, 1999
). In the current study, we investigated
whether treatment with dietary saturated fatty acids could reverse
established alcoholic liver injury despite continued administration of
ethanol. We show that diets enriched in saturated fatty acids improved
both histological liver injury and biochemical parameters that have
been etiologically linked to liver injury.
| |
Materials and Methods |
|---|
|
|
|---|
Animal Model.
Male Wistar rats (Harlan Bioproducts for
Science, Indianapolis, IN) weighing between 225 and 250 g
were fed a liquid diet by continuous infusion through permanently
implanted gastric tubes as previously described (French et al., 1986
;
Tsukamoto et al., 1990
). The rats received their total nutrient intake
by intragastric infusion. This was achieved by joining two tubes, one
carrying ethanol from one syringe pump and the other carrying diet from a second pump, so that ethanol and diet could be varied at will. Vitamins and minerals were given as described previously (French et
al., 1993
) The dose of ethanol was increased slowly, as tolerance developed, to maintain blood alcohol levels in the range of 150 to 300 mg/dl. The starting dose was 10 g/kg/day; the final dose was 16 g/kg/day. Each ethanol-fed rat underwent at least two measurements of
blood alcohol level.
|
80°C. The studies were conducted according to
the guidelines on care and use of laboratory animals established by the
National Institutes of Health.
|
Histopathological Analysis Including Sirius Red Staining for
Collagen.
A small sample of liver was obtained by biopsy or at
death and fixed in formalin. Hematoxylin and eosin stain was used for light microscopy. The severity of liver pathology was assessed as
follows: steatosis (the percentage of liver cells containing fat), 1+,
25% of cells containing fat; 2+, 26 to 50%; 3+, 51 to 75%; and 4+,
>75%. Necrosis was evaluated as the number of necrotic foci per
square millimeter; inflammation was scored as the number of
inflammatory cells per square millimeter. At least three different
sections were examined per sample of liver. The pathologist evaluating
these sections was unaware of the treatment the rats had received.
Measurement of Blood Alcohol Levels. Blood was collected from the tail vein, and ethanol concentration was measured using the alcohol dehydrogenase kit from Sigma Chemical (St. Louis, MO).
Measurement of Plasma Endotoxin Levels.
Blood samples were
collected in endotoxin-free vials (Sigma Chemical) and measured as
previously described (Nanji et al., 1997a
).
Determination of Thiobarbituric Acid-Reactive Substances (TBARS)
and Conjugated Dienes.
Levels of liver TBARS were measured
according to the method of Ohkawa et al. (1979)
. Conjugated dienes in
the total lipid extracted from liver homogenates were identified by
their optical density of between 220 and 300 nm as described by
Recknagel and Glende (1984)
.
Measurement of Nonheme Iron.
Nonheme iron was determined in
liver homogenate as described previously with ferene S, as an indicator
with the molar absorptivity of 35,500 M
1
cm
1 at 594 nm (Artiss et al., 1982
).
Aniline Hydroxylase Assay.
Aniline hydroxylase assays were
performed as described previously (Imai et al., 1966
; Waxman et al.,
1989
). Liver microsomes were incubated for 60 min at 37°C in 0.45 ml
of 0.1 mol/l potassium phosphate, pH 7.4, containing 8 mM
aniline and 1 mM NADPH. Reactions were terminated with 90 µl of 40%
trichloroacetic acid. Samples were then placed on ice for 10 min
followed by 10 min of centrifugation. An aliquot of the supernatant
(0.36 ml) was mixed with 10%
Na2CO3 (0.24 ml) and 2%
phenol (0.36 ml). A630 values were
determined after incubation for 45 min in the dark. Specific activities
were calculated from a standard curve prepared with the reaction
product 4-aminophenol (Aldrich Chemical, Milwaukee, WI).
Determination of NF-
B Binding Activity and I
B
Protein
Levels in Liver.
Electrophoretic mobility shift assays (EMSAs)
were used to determine the binding activity of NF-
B and were
performed essentially as described in previous studies (Lin et al.,
1997
; Nanji et al.; 1999
). Equal amounts of protein were incubated with
a 5'-32P-labeled oligonucleotide containing a
NF-
B consensus site. The incubation mixtures were separated on a 7%
nondenaturing polyacrylamide gel and bands were detected by
autoradiography. The specificity of binding was determined by prior
addition of 100-fold excess of unlabeled competitor consensus oligonucleotide.
B
was conducted using 50 µg of
cytosolic protein. Samples were electrophoresed on a 10% sodium dodecyl sulfate-polyacrylamide gel and proteins were then
electroblotted onto polyvinylidene difluoride membranes (Sigma
Chemical). Membranes were incubated with the primary antibody against
I
B
(Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of
1:500 in 1% nonfat milk Tween-phosphate-buffered saline. Membranes
were then incubated with a secondary antibody (horseradish
peroxidase-conjugated goat anti-rabbit immunoglobulin G) at a dilution
of 1:10,000.
Determination of mRNA Levels for TNF-
, Cox-2, Cox-1, and
-Actin.
To examine the expression of Cox-1, Cox-2, TNF-
, and
-actin in liver tissue, total RNA was isolated according to the
guanidinium isothiocyanate method (Chomczynski and Sacchi, 1987
). The
integrity of RNA was assessed by agarose gel electrophoresis and
ethidium bromide staining. Reverse transcription-polymerase chain
reaction was performed as previously described (Nanji et al., 1997a
).
The sequences of primer pairs, 5' and 3', and predicted sizes of the amplified PCR fragments of Cox-1, Cox-2, TNF-
, and
-actin have been reported previously (Nanji et al., 1994c
, 1997a
,b
). PCR products and molecular size markers were subjected to electrophoresis on 1%
agarose gels and visualized by means of ethidium bromide staining. The
gels were analyzed by laser scanning densitometry with a Molecular Dynamics densitometer and Image Quant software (Molecular Dynamics, Sunnyvale, CA). Each experiment included a negative control (sample RNA
that had not been subjected to reverse transcription). This sample did
not yield a PCR product, confirming the absence of extraneous genomic
DNA or PCR products contaminating the samples. Varying the number of
PCR cycles did not change the relative differences between the samples,
indicating that the PCR conditions were not within the plateau phase of
amplification. All amplification reactions of one experiment were
performed in parallel in the same heating block to ensure compatible conditions.
Statistical Analysis. Results are presented as means ± S.D. Comparison among groups was performed by one-way analysis of variance. The paired t test was used to evaluate differences in pathological changes in the same animals after switching to the saturated fatty acid-enriched diets.
| |
Results |
|---|
|
|
|---|
There was no significant difference in weight gain or levels of blood alcohol among the various groups. The levels of blood alcohol (mg/dl) in the different groups were fish oil-ethanol, 8 weeks, 226 ± 62; fish oil-ethanol, 6 weeks, 238 ± 53; fish oil-ethanol and palm oil-ethanol, 257 ± 62; and fish oil-ethanol and MCT-ethanol, 221 ± 64.
Effect of Experimental Diets on Liver Pathology.
Feeding a
fish oil-ethanol diet for 6 (group 2) or 8 weeks (group 1) caused fatty
liver, necrosis, and inflammation (Table 2). Control animals fed the fish
oil-dextrose diet (group 5) showed no pathological changes. Significant
improvement in hepatic pathology occurred when the fish oil-ethanol
diet was discontinued and replaced with either palm oil-ethanol (group
3) or MCT-ethanol (group 4). Necrosis and inflammation were virtually
absent in these two groups (3 and 4). In contrast, the degree of fatty
liver did not decrease in these two groups.
|
|
Dietary Modulation of Endotoxemia and Lipid Peroxidation.
We
also determined the effects of different diets on known mediators of
hepatic injury (Table 3). Concentrations
of endotoxin in plasma and hepatic TBARS and conjugated dienes
decreased significantly after institution of the palm oil- and
MCT-containing diets. Activity of CYP 2E1 and liver nonheme iron levels
were also significantly decreased after administration of palm oil and
MCT diets (Table 3).
|
Effects of Experimental Diets on Activation of NF-
B.
To
evaluate the activation of NF-
B, EMSA of nuclear extracts from whole
liver were carried out. NF-
B binding activity was increased in the
fish oil-ethanol fed groups (Fig. 3). To
prove specificity, a 100-fold excess of unlabeled NF-
B or
STAT (signal transducer and activator of transcription)
oligonucleotide was added to an EMSA-binding reaction. Although
addition of the NF-
B oligonucleotide completely abrogated complex
formation, addition of STAT 3 oligonucleotide had no effect (data not
shown). Activation of NF-
B was absent or barely detectable in the
FE-PE and FE-MCTE groups. NF-
B activation was absent in rats fed
fish oil and dextrose.
|
B might be the result of
degradation of IkB
, amounts of IkB
were measured by Western blot
analysis. In livers from rats fed fish oil and ethanol, a marked
decrease in IkB
was observed (Table 4;
Fig. 3). In the FE-PE and FE-MCTE groups, the levels were similar to
those seen in dextrose-fed controls. Thus, preservation of IkB
protein in the FE-PE and FE-MCTE groups coincided with the absence of
activation of NF-
B; in contrast, loss of IkB
protein coincided
with NF-
B activation in fish oil-ethanol-fed rats.
|
Effect of Experimental Diets on Cox-2 and TNF-
.
As
mentioned above, we have proposed that lipid peroxidation and endotoxin
activate NF-
B which lead, in turn, to induction of TNF-
and Cox-2
in alcoholic liver injury (Fig. 4). Thus,
we also measured the effects of different diets on levels of mRNA for
TNF-
, Cox-2, Cox-1, and
-actin. We have previously demonstrated that levels of TNF-
and Cox-2 mRNAs are too low to be detected by
Northern blot or ribonuclease protection assays (Nanji et al., 1997a
).
Reverse transcription-polymerase chain reaction was used for these
measurements. Administration of fish oil-ethanol led to an increase in
amounts of Cox-2 and TNF-
mRNAs. In contrast, replacing the fish oil
with palm oil (FE-PE) or MCT (FE-MCTE) led to marked down-regulation of
both TNF-
and Cox-2 (Table 4). Levels of mRNA for Cox-1, which is
the constitutive isoform of the enzyme, were similar in all groups
(Table 4).
|
| |
Discussion |
|---|
|
|
|---|
Relationship of Rat Model of Alcohol-Induced Liver Injury to Human
Alcoholic Liver Disease.
The main problem in the management of
alcoholic liver disease remains the inability of patients to abstain
from alcohol. Many studies have been carried out, therefore, to
determine the effectiveness of therapy in reducing the progression of
liver injury in alcoholics (Fulton and McCullough, 1998
). The current
data are important in this regard because the experimental model used
has striking similarities to the clinical setting in which alcoholic
liver disease occurs.
Mechanisms by Which Saturated Fatty Acids Down-Regulate
Pathological Events Triggered by Ethanol.
It is well accepted that
endotoxin and lipid peroxides are hepatotoxic and levels of both
increase in alcohol-induced liver injury (Nanji et al., 1993
; Adachi et
al., 1995
; Kaplowitz and Tsukamoto, 1996
; Polavarapu et al., 1998
). The
observed differences in liver pathology in rats fed ethanol with fish
oil and then switched to either palm oil or MCT can be explained, in
part, by differences in levels of endotoxin and lipid peroxides. For example, rats fed fish oil and ethanol for either 6 or 8 weeks had the
highest levels of endotoxin and lipid peroxidation. Animals treated
with palm oil (FE-PE) or MCT (FE-MCTE) even with continued administration of ethanol had an approximately 60 to 80% reduction in
endotoxin and lipid peroxide levels. In fact, in the FE-PE and FE-MCTE
groups, the lipid peroxide levels were similar to those seen in the
fish oil-dextrose-fed rats. The increase in endotoxin levels in
ethanol-fed rats reflects a combination of increased gut permeability
and a decreased ability of Kupffer cells to detoxify endotoxin (Nanji
et al., 1993
). The reduction in endotoxin levels after treatment with
saturated fatty acids is likely a result of improvement in liver
function although alterations in gut permeability cannot be excluded.
Role of NF-
B, TNF-
, and Cox-2.
One pathway by which
endotoxemia and lipid peroxidation act in concert to promote alcoholic
liver injury is via NF-
B. NF-
B is a ubiquitous transcription
factor that is implicated in the activation of many genes, including
those involved in alcoholic liver injury (May and Ghosh, 1997
; Nanji et
al., 1999
). The results of this study confirm our previous finding that
activation of NF-
B occurs in association with development of
necroinflammatory changes in the liver (Nanji et al., 1999
). In
addition, we show that the reduction in necrosis and inflammation
induced by treatment with saturated fatty acid is accompanied by a
marked reduction of NF-
B activation. The saturated fatty
acid-induced inhibition of NF-
B activation was accompanied by
increased amounts of I
B
. The mechanism by which saturated fatty
acids stabilize I
B
and suppress NF-
B activation remains to be
elucidated, but a role for decreased levels of endotoxin and lipid
peroxidation is likely. Although we did not, in the present study,
identify the specific cell types expressing NF-
B, based on our
previous study (Nanji et al., 1999
) and those of others (Lin et al.,
1997
), we expect that the Kupffer cell is the major cell type showing
activation of NF-
B. We cannot, however, exclude the contribution of
hepatocytes, and endothelial and stellate cells to activation of
NF-
B in liver. In contrast to the proinflammatory cascade of genes
expressed in response to activation of NF-
B in Kupffer cells,
activation of NF-
B in hepatocytes may serve a hepatoprotective role,
by stimulating cellular regeneration and inhibition of apoptosis (Schmid and Adler, 2000
). Thus, the cellular site of activation of
NF-
B may determine the balance between necroinflammatory changes and hepatoprotection.
B can enhance expression of several genes,
including TNF-
and Cox-2 (Barnes and Karin, 1997
and Cox-2 occurred in conjunction with suppression of NF-
B.
Although it is difficult, if not impossible, to delineate the
contribution of each of the individual factors to the overall problem
of alcohol-induced liver injury, a growing body of evidence implicates
activation of NF-
B with subsequent up-regulation of proinflammatory
cytokines and Cox-2 in the causation of liver injury (Fig. 4).
Relevance of Observed Changes to Human Alcoholic Liver
Disease.
The development of an appropriate animal model for
alcoholic liver disease has been difficult because multiple factors
interact, leading to pathological changes characteristic of alcoholic
liver disease. The liver pathology in rats fed ethanol intragastrically has been compared with histological findings in human alcoholic liver
disease (Hall et al., 2001
). Hepatomegaly, increased levels of
transaminases in serum, balloon degeneration, apoptosis,
megamitochondria, necrosis, inflammation, and fibrosis are seen in both
clinical and experimental alcoholic liver injury. Also of note is that cirrhosis is not seen in rats administered ethanol unless carbonyl iron
is supplemented in the diet (Tsukamoto et al., 1995
).
B.
| |
Footnotes |
|---|
Accepted for publication August 8, 2001.
Received for publication May 15, 2001.
Address correspondence to: Dr. Amin A. Nanji, Clinical Biochemistry Unit, LG 136, Block K, Queen Mary Hospital, 102 Pokfulam Rd., Hong Kong, China. E-mail: ananji{at}pathology.hku.hk
| |
Abbreviations |
|---|
NF-
B, nuclear factor-
B;
TNF-
, tumor
necrosis factor-
;
Cox, cyclooxygenase;
MCT, medium-chain
triglyceride;
TBARS, thiobarbituric acid-reactive substances;
EMSA, electrophoretic mobility shift assay;
CYP 2E1, cytochrome P450 2E1;
FE-PE, fish oil-ethanol-palm oil-ethanol;
FE-MCTE, fish
oil-ethanol-medium-chain triglyceride-ethanol.
| |
References |
|---|
|
|
|---|
B
A pivotal factor in chronic inflammatory diseases.
N Engl J Med
336:
1066-1071
B activation and cytokine gene expression by rat hepatic macrophages.
Am J Physiol
272:
G1355-G1364
B and I
B proteins
An overview.
Semin Cancer Biol
8:
63-73[Medline].
and reverse fibrosis in alcoholic liver disease in the rat.
Hepatology
26:
1538-1545[Medline].
B/Rel/I
B: implications in gastrointestinal disease.
Gastroenterology
118:
1208-1228[Medline].This article has been cited by other articles:
![]() |
J. Mane, E. Pedrosa, V. Loren, I. Ojanguren, L. Fluvia, E. Cabre, G. Rogler, and M. A. Gassull Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis in Interleukin-10-Deficient Mice J. Nutr., March 1, 2009; 139(3): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. You, Q. Cao, X. Liang, J. M. Ajmo, and G. C. Ness Mammalian Sirtuin 1 Is Involved in the Protective Action of Dietary Saturated Fat against Alcoholic Fatty Liver in Mice J. Nutr., March 1, 2008; 138(3): 497 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Baumgardner, K. Shankar, L. Hennings, T. M. Badger, and M. J. J. Ronis A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G27 - G38. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Lee, J. S. Yan, R. K. Ng, S. Kakar, and J. J. Maher Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury J. Lipid Res., August 1, 2007; 48(8): 1885 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonzalez-Periz, A. Planaguma, K. Gronert, R. Miquel, M. Lopez-Parra, E. Titos, R. Horrillo, N. Ferre, R. Deulofeu, V. Arroyo, et al. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA FASEB J, December 1, 2006; 20(14): 2537 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cabre, J. M Hernandez-Perez, L. Fluvia, C. Pastor, A. Corominas, and M. A Gassull Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study Am. J. Clinical Nutrition, March 1, 2005; 81(3): 692 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. J. Ronis, R. Hakkak, S. Korourian, E. Albano, S. Yoon, M. Ingelman-Sundberg, K. O. Lindros, and T. M. Badger Alcoholic Liver Disease in Rats Fed Ethanol as Part of Oral or Intragastric Low-Carbohydrate Liquid Diets Experimental Biology and Medicine, April 1, 2004; 229(4): 351 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. J. Ronis, S. Korourian, M. Zipperman, R. Hakkak, and T. M. Badger Dietary Saturated Fat Reduces Alcoholic Hepatotoxicity in Rats by Altering Fatty Acid Metabolism and Membrane Composition J. Nutr., April 1, 2004; 134(4): 904 - 912. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||